Clinical Trial

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty

Study acronym: NOVABLOC-TKA
Recruiting
View on ClinicalTrials.gov →
Summary
Multi-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-03-30 -> 2026-12-31 2026-04-21
minor Completion pushed: 2026-03-30 -> 2026-12-31 2026-04-21
Trial Details
NCT Number NCT07191067
Lead Sponsor Synaptrix, Inc.
Conditions Pain
Enrollment 120 participants
Start Date 2025-09-30
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29